Back to Trades
Girao Tiago
Chief Financial OfficerCIK 0001618670
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2026
Girao Tiago, Chief Financial Officer, has filed 4 SEC reports (2026), all concentrated in Immunovant, Inc. (IMVT), totaling $3.5M in disclosed volume. Weighing $0 bought versus $835.9K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Oct 30 | IMVT Immunovant, Inc. | Girao Tiago | Chief Financial Officer | Sell | $188.3K |
| Jul 24 | IMVT Immunovant, Inc. | Girao Tiago | Chief Financial Officer | Sell | $263.0K |
| Jun 26 | IMVT Immunovant, Inc. | Girao Tiago | Chief Financial Officer | Sell | $384.6K |
| Apr 9 | IMVT Immunovant, Inc. | Girao Tiago | Chief Financial Officer | Grant | $2.3M |
4 filings